johnson & johnson news - Search News

Intra-Cellular, Johnson & Johnson

The Wall Street Journal on MSN · 43m

Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal

Johnson & Johnson agreed to acquire mental-illness drug developer Intra-Cellular Therapies for about $15 billion.

Barron's on MSN · 1h

Johnson & Johnson in $14.6 Billion Deal to Buy Biotech Intra-Cellular

Johnson & Johnson has entered an agreement to acquire all outstanding shares of Intra-Cellular Therapies, in a multibillion-dollar bet on mental health therapies. Johnson & Johnson will pay $132 per share in cash for a total equity value of $14.

FiercePharma · 2h

JPM25: Johnson & Johnson makes a splash, buying out Intra-Cellular Therapies for $14.6B

At $132 per share, J&J paid a 39% premium on Friday’s closing price of Intra-Cellular, a New York City based biotech that develops and markets products for the central nervous system.

Bears interview Lions assistants Ben Johnson, Aaron Glenn

CBS Chicago on MSN · 1d

Bears interview Lions offensive coordinator Ben Johnson and defensive coordinator Aaron Glenn for head coaching job

The Chicago Bears interviewed Detroit Lions offensive coordinator Ben Johnson and defensive coordinator Aaron Glenn for their head coach position on Saturday. Both Johnson and Glenn have been looked at as top candidates this cycle,

Fox Sports · 1d

Bears interview Lions assistants Ben Johnson, Aaron Glenn for head coaching position

The Chicago Bears have interviewed Detroit Lions offensive coordinator Ben Johnson and defensive coordinator Aaron Glenn for their head coaching position

Reuters on MSN · 1d

Lions OC Ben Johnson talks to Bears about head coach job

Detroit Lions offensive coordinator Ben Johnson, one of the hottest candidates on the 2025 head coaching circuit, interviewed for the Chicago Bears' top job, the team announced Saturday. Johnson, 38,

2d

Johnson & Johnson Could Serve As High-Yield Bond Alternative

Johnson & Johnson remains a Buy for its stability and consistent dividends, despite short-term price fluctuations and modest ...

4d

Cautious Outlook on Johnson & Johnson Amid Currency and Legal Challenges

Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...

2don MSN

Johnson & Johnson stock outperforms competitors despite losses on the day

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Johnson & Johnson MedTech halts Varipulse PFA cases due to stroke reports

Johnson & Johnson MedTech has temporarily paused all U.S. external evaluations and cases using its Varipulse pulse field ...

2d

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Johnson & Johnson (JNJ) And Encourages Investors to Reach Out

NEW YORK, NY / ACCESSWIRE / January 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf ...

5d

Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer

Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results